Introduction {#S1}
============

The serotonin system modulates a wide range of neural outcomes from emotion to intellect to metabolism and it is a target of pharmacotherapies, steroid hormones, cytokines, neuropeptides and trophic factors, all of which impact the generation and efficacy of serotonin neurotransmission. Recently, it has been suggested that antidepressants and other pharmacotherapies may act by promoting neuronal plasticity ([@R1]). The underlying structural element of neuronal plasticity in the adult nervous system is the dendritic spine ([@R2]). In addition, dendritic spines are the morphological basis for excitatory neurotransmission ([@R3], [@R4]). Hence, dendritic spine proliferation on serotonin neurons would have a profound effect on serotonergic function and neurotransmission.

A significant body of literature has demonstrated that estrogen (E) increases dendritic spines in hippocampal neurons ([@R5], [@R6]). We hypothesized that ovarian steroids support neuronal plasticity by enhancing dendritic spine proliferation on serotonin neurons. In the adult nervous system, this would facilitate excitatory input to the serotonin neurons and in turn, increase serotonin neural activity.

The extension of dendrites requires a multiplex intracellular cascade that culminates in dynamic actin reorganization ([@R2]). This reorganization requires extension and branching of actin at the cell membrane as well as degradation of actin further back in the spine. Upstream of actin dynamics are effector proteins that are activated by Rho GTPases. The most well accepted of these are CDC42, Rac 1 and Rho A. These small molecules activate cascades that lead to filopodia extension, spine head enlargement and spine shortening, all of which are necessary for the production of a mature dendritic spine.

This laboratory has devoted effort toward understanding the actions of ovarian hormones in serotonin neurons and their terminal fields with a macaque model of surgical menopause. Serotonin neurons express estrogen receptor beta (ERβ) and progestin receptors (PR) ([@R7], [@R8]). We found that E, plus or minus P supplementation, regulates the expression of pivotal serotonin-related genes and proteins in the monkey dorsal raphe in a pattern suggestive of increased serotonin production, increased serotonin turnover, increased neural firing and decreased degradation ([@R9]--[@R11]).

We recently reported that ovarian steroids regulate gene expression in laser captured serotonin neurons in a manner that would increase cellular resilience and decrease apoptosis ([@R12]). Further examination of the proteins implicated by gene expression showed that in normal, undamaged midbrain, ovarian steroids act through the caspase independent pathway and decrease translocation of apoptosis inducing factor (AIF) from the mitochondria to the nucleus ([@R13]).

The additional issue of steroid supported dendritic spine proliferation may be extremely important for menopausal women grappling with issues surrounding hormone therapy (HT). Women experience ovarian failure and loss of ovarian steroid production around 50 years of age. Thus, with extended life spans, a woman may live 35--40 years without ovarian steroids. If dendritic spines on serotonin neurons shrink or atrophy due to lack of steroid supported gene expression, then geriatric depression, anxiety, fretfulness, decreased coping skills and increased vulnerability to stress can be predicted outcomes.

Therefore, in this study, we sought novel genes related to dendritic spine protrusion that are regulated by estrogen (E) and progesterone (P) in laser captured serotonin neurons of rhesus monkeys using the Rhesus Affymetrix cDNA array and nested quantitative (q) RT-PCR. Fifteen pivotal gene changes predicted by the microarray were confirmed by qRT-PCR.

Materials and Methods {#S2}
=====================

The Oregon National Primate Research Center (ONPRC) Institutional Animal Care and Use Committee approved this study.

Animals and treatments {#S3}
----------------------

Nine adult female rhesus monkeys (*Macaca mulatta*) were spayed (ovariectomized only) by the surgical personnel of ONPRC between 3 and 8 months before assignment to this project according to accepted veterinary surgical protocol. All animals were born in China, were aged between 7--14 years by dental exam, weighed between 4 and 8 kg, and were in good health.

Animals were either treated with placebo (**ovx-control group; n=3**), or treated with estrogen (E) for 28 days (**E group; n=3**), or treated with E for 28 days and then supplemented with P for the final 14 of the 28 days (**E+P group; n=3**). The placebo treatment of the spay-control monkeys consisted of implantation with empty Silastic capsules (s.c.). The E-treated monkeys were implanted (s.c.) with two 4.5-cm E-filled Silastic capsules (i.d. 0.132 in.; o.d. 0.183 in.; Dow Corning, Midland, MI). The capsule was filled with crystalline estradiol (1,3,5(10)-estratrien-3,17-b-diol; Steraloids, Wilton, NH). The E+P- treated group received E-filled capsules, and 14 days later, received one 6-cm capsule filled with crystalline P (4-pregnen-3,20 dione; Steraloids). All capsules were placed in the periscapular area under ketamine anesthesia (ketamine HCl, 10mg/kg, s.c.; Fort Dodge Laboratories, Fort Dodge, IA).

The monkeys were euthanized at the end of the treatment periods according to procedures recommended by the Panel on Euthanasia of the American Veterinary Association. Each animal was sedated with ketamine, given an overdose of pentobarbital (25 mg/kg, i.v.), and exsanguinated by severance of the descending aorta.

Steroid Hormone Assays {#S4}
----------------------

Assays for estradiol and progesterone were performed utilizing a Roche Diagnostics 2010 Elecsys assay instrument and the serum levels achieved by the implants were previously reported ([@R12])

Tissue preparation for Laser Capture Dissection (n=9; 3 animals/treatment group) {#S5}
--------------------------------------------------------------------------------

The left ventricle of the heart was cannulated and the head of each animal was perfused with 3 liters of 1× cold RNA-later buffer (Ambion Inc., Austin, TX) plus 20% sucrose. The brain was removed from the cranium, dissected into blocks and frozen at −80°C. The pontine midbrain block was placed in a cryostat (Microm HM500OM) and brought to −20°C. Thin sections (7 µm) through the dorsal raphe nucleus were thaw mounted onto plain glass slides and frozen at −80°C. The next morning, the sections were processed in a rapid, RNAse free immunohistochemical assay for tryptophan hydroxylase (TPH). The sections were immersed in cold acetone for 1 minute, cold ethanol for 30 seconds, cold PBS for 3 minutes, and then covered with normal rabbit serum (NRS, 1/500) containing 1% RNAse inhibitor for 10 minutes. The NRS was blotted and the sections were covered with sheep anti-TPH (1/300; Chemicon, Temecula, CA) containing 1% RNAse inhibitor for 30 minutes, then immersion washed in PBS for 3 minutes, and covered with biotinylated rabbit anti-sheep serum (1/120; Vector Laboratories, Burlingame, CA) containing 1% RNAse inhibitor for 20 minutes. The sections were then immersed in PBS for 3 minutes, covered with Vector ABC reagent for 30 minutes, immersed in cold 0.2 M Tris (pH 8.2), immersed in cold diaminobenzidine (DAB) containing H2O2 (30% solution diluted 1/5000) and dehydrated in 100% ethanol for 2 minutes. Finally, the slides were immersed in xylene for 2 minutes and then dried under vacuum for 1 hr prior to laser capture. Serotonin neurons appeared darkly stained and were captured with an Arcturus Laser Dissection Microscope (PixCell II). After capture to the microcap film (Capsure macro-211), the films were removed from the caps and immersed in lysis buffer. Up to 10 films with 1000--3000 pulses each were collected into one microtube containing 200 µl of lysis buffer. Approximately 150,000 laser pulses were conducted for a pool (12--15 microtubes were pooled). Individuals interested in obtaining other areas of the brain for similar studies are encouraged to contact the senior author.

RNA extraction from laser captured neurons {#S6}
------------------------------------------

Two pools were prepared from two placebo, two E-treated and two E+P treated animals. One of the pools was used for hybridization to the microarray and one pool was set aside for qRT-PCR. An additional pool was prepared from another placebo, E-treated and E+P treated animal for qRT-PCR. Thus, 2 animals per group were used for hybridization and 3 animals per group were used to confirm gene changes with qRT-PCR.

The tubes containing the lysis buffer and films were vortexed to dislodge the captured material from the films. Each tube was adjusted to 350 µl of lysis buffer and then 350 µl of 70% ethanol was added and mixed well. The samples were extracted with the RNAeasy microRNA kit from Qiagen according to the directions. The final eluates were pooled and evaporated in a Speedvac. The RNA was suspended in 12 µl of TE (0.01MTris+0.005M EDTA). The quantity of RNA in the resuspended sample was determined with the Ribogreen Quantitation Kit (Molecular Probes, Eugene, OR) or with a Nanodrop Spectrophotometer (ND 1000 V3.3, Wilmington, DE). The integrity of the RNA was examined with the Agilent Bioanalyzer using the pico-chip according to the directions of the manufacturer.

Affymetrix hybridization {#S7}
------------------------

Labeled target cRNA was prepared from 6 pools of laser captured serotonin neurons (n=2 animals/treatment group). The cRNA was hybridized to Rhesus Affymetrix GeneChip arrays. The Affymetrix GeneChip® Rhesus Macaque Genome Array interrogates over 47,000 M. mulatta transcripts. The array contains 52,024 rhesus probe sets and was designed using public data sources including data from the University of Nebraska (R. Norgren), the Baylor School of Medicine's rhesus macaque whole-genome shotgun assembly (October 1, 2004), and GenBank® STSs, ESTs, and mRNAs up to March 30, 2005. Additionally, probe sets were designed to interrogate rhesus transcripts orthologous to the 3' end of human transcrips (GeneChip® Human Genome U133 Plus 2.0 Array and RefSeq sequences up to March 2005), sixteen viral sequences from human and other primate species, three different rhesus r(ribosomal)RNAs, and thirteen rhesus mitochondrial genes along with control and reporter sequences. Microarray assays were performed in the Affymetrix Microarray Core of the OHSU Gene Microarray Shared Resource.

Data Analysis with GeneSifter Software {#S8}
--------------------------------------

The data was processed with Affymetrix GCOS interface software and compressed into CHP files and uploaded to GeneSifter (VisX Labs, Seattle, WA). The software calculated the mean signal intensity and the standard error of the mean for each treatment group. Probe sets that were undetectable in all treatment groups were eliminated. The remaining probe sets were filtered and those probes sets exhibiting a 2-fold or greater change between the treatment groups were subjected to KEGG analysis. The use of a 2-fold filter was chosen based upon a survey of other microarray studies. Probe sets with robust signal intensities that showed a 2-fold or greater change with E or E+P and that were consistent across multiple representations on the chip were reported. Individuals interested in obtaining the raw data are encouraged to contact the senior author.

Nested Quantitative (q) RT-PCR {#S9}
------------------------------

A second laser capture pool was made from the 6 animals used for the microarrays, plus an additional 3 animals, yielding 9 laser capture pools (3 animals/treatment group) for qRT-PCR confirmation of 15 pivotal genes which were: RhoA, Rac1, CDC42, ROCK, PIP5k, IRSp53, WASP, WAVE, ARP3, gelsolin, profilin, cofilin, LIMK2, CRIPAK1 and MLCK. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH), GUSB and PIAA were measured for reference. GAPDH was used for normalization of the data.

Complementary DNA (cDNA) synthesis was performed using Oligo-dT 15 and *Random hexamer* primer (Invitrogen Life Technologies, Carlsbad, CA) and Superscript III reverse transcriptase (200 U/µg of RNA, Invitrogen Life Technologies) at 42C for 1 hr. cDNA was treated with RNAse H to disintegrate dsDNA. Total RNA (1.4 to 1.8 µg) from each Laser capture pool and from a pool of rhesus tissues was transcribed and stored as cDNA at a concentration of 250 ng/µl.

The cDNA (10--20 ng) from each laser capture pool and from the rhesus tissue pool (100ng cDNA) was used in a 50 µl multiplex PCR reaction with Platinum Taq polymerase (Invitrogen Life technology, Carlsbad, CA). Each of the external primer sets (20 µM) was added to the multiplex PCR reaction. Then, 1µl was removed for each of the internal primer sets and the quantitative polymerase chain reaction. qPCR was conducted with Platinum SYBR-Green qPCR Super Mix UDG (Invitrogen Life Technologies). The reaction (final volume 20 µl) contained 1 µl PCR product of external PCR reaction, 10 µM of forward and reverse primers and 1× SYBR-Green ER qPCR mix Invitrogen (11760-500). PCR Mastermix contains a modified Platinum DNA Taq Polymerase, uracil DNA glycosylase (UDG) and SYBR-Green II fluorescent dye, which is specific for double stranded DNA. In addition, 500 nM of ROX was added to control PCR artifacts and to control the baseline of the multiplex reaction. There was a *log linear* increase in fluorescence detected as the concentration of amplified double stranded product cDNA increased during the reaction. The fluorescence was detected as cycle threshold (Ct) with an ABI 7900 thermal cycler during forty cycles. A standard curve was generated with a pool of RNA from various rhesus tissues and rhesus embryonic stem cells (rhesus standard pool). The PCR product from the multiplex reaction on the rhesus standard pool was diluted to generate a standard curve for each of the internal primer sets. The slope of the curve was used to calculate the relative pg of each transcript in the RNA extracted from the laser captured pools. Then, the ratio of each transcript to GAPDH was calculated.

Validation of Nested PCR {#S10}
------------------------

Initially, cold PCR was conducted for all primer sets using cDNA from the rhesus tissue pool to verify that the internal reactions produced one product. To further verify PCR amplification, the product of the internal qPCR reaction was sequenced.

Primer selection {#S11}
----------------

For our genes of interest, the probe set ID was saved as a .txt file. This file was launched to batch query at Affymetrix Netaffix program on the web. This program enabled retrieval of the annotation list of the genes of interest and provides direct access to Genebank sequence at NCBI. Thus, using Netaffix, the oligonucleotide location on each cDNA sequence was identified. Based upon the oligoset distribution, a target area of each gene of interest was selected. The target sequence was then loaded into Primer Express software, which chooses the primers for optimum qRT-PCR. For each gene, two sets of primers were generated; set one was used to generate an external larger PCR product of about 400bp--600bp. The second set was used to amplify internal or nested PCR product of about 250bp--350bp off of the larger product. The primers utilized for qRT-PCR on the RNA extracted from the laser-captured serotonin neurons are shown in [Table 1](#T1){ref-type="table"}.

Statistical analysis {#S12}
--------------------

The average signal intensities on the microarrays in the E and E+P groups were examined for 2-fold or greater increases or decreases from the ovx-control group (n=2 animals or chips/group). No further statistical test was performed on the signal intensities. The average relative expression of the 3 groups (n=3 animals/group) from the qRT-PCR assay was first compared with ANOVA followed by Student-Newman-Keuls posthoc pairwise comparison. In a few comparisons, the variance within one group hindered the ANOVA analysis. This was not unusual for this type of preparation, and more animals would likely reduce the variance. However, labor and cost were prohibitive. Therefore, a two-tailed t-test was performed in which each treatment group was compared to the ovx-control group. To confirm the variance was significantly different between groups, an F test was performed. Hence, the mean of a treatment group was significantly different from the ovx-control group with Student-Newman-Keul's or a t-test; or the variance within the treatment group was significantly different from the ovx-control group with an F test. Either result indicates that the groups are different. Comparisons were considered significant when there was greater than a 95% chance that the groups were different (p\<0.05). Prism 5.0 from Graph Pad (San Diego, CA) was used for all comparisons.

Results {#S13}
=======

Expression Changes Related to Dendritic Spines in Laser Captured Serotonin Neurons {#S14}
----------------------------------------------------------------------------------

[Figure 1](#F1){ref-type="fig"} illustrates the 2-fold changes in gene expression that were detected on the microarrays. Genes in red increased 2-fold or greater in animals treated with E or E+P. Genes in blue decreased 2-fold or greater in animals treated with E or E+P. There was increase in expression of RhoA, Rac1, and cdc42 in the E or E+P treated animals. Downstream of CDC42, there was an increase in expression of IRSp53, WASP, WAVE and subunits of actin related protein (ARP2/3), which promotes actin enucleation, branching, polymerization and spine head enlargement. Downstream of Rac1, there was an increase in expression of PIP5K and the actin regulatory proteins, cofilin, gelsolin and profilin, which reduce actin dynamics, stabilize actin filaments and thereby stabilize spines. Also downstream of Rac1, there was a decrease in expression of CRIPAK1, LIMK2 and MLCK, which could maintain activation of cofilin. Downstream of RhoA, there was an increase in expression of ROCK2 and MLC, which code for proteins that facilitate actinomysin contractility and spine shortening. MLCK is also known as MYLK. The microarray results were confounding as there were both increases and decreases in probe sets with these acronyms. We show them in red and blue on the figure and performed qRT-PCR for confirmation below. [Table 2](#T2){ref-type="table"} contains the average signal intensities for the probe sets corresponding to each of these genes from the duplicate microarray chips in each group. The results of the 6 Affymetrix microarray chips have been submitted to the Gene Expression Omnibus public database and assigned the GEO accession number GSE16169.

Validation of Expression Changes in Laser Captured Serotonin Neurons {#S15}
--------------------------------------------------------------------

Significant increases in expression of RhoA, Rac1, CDC42, ROCK, PIP5k, IRSp53, WASP, WAVE, cofilin, gelsolin, profilin, and ARP3; and significant decreases in expression of LIMK2, CRIPAK1 and MLCK, were confirmed with nested qRT-PCR and the results are shown in [Figures 2](#F2){ref-type="fig"}--[4](#F4){ref-type="fig"}. In [Figures 2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}, there were different patterns of increased expression. That is, RhoA, Rac1 and PIP5K increased with E and then returned to placebo levels with supplemental P; whereas CDC42, ROCK2, IRSp53, WASP, ARP3 and cofilin increased with E and remained elevated with supplemental P; and finally WAVE and profilin increased only with E+P. Similarly, MLCK and CRIPAK were decreased with E and E+P whereas LIMK was decreased with E+P only.

Steroid Hormone Verification {#S16}
----------------------------

The concentration of E and P in a serum sample obtained from each animal at necropsy was obtained to verify the efficacy of the Silastic implants. The concentration of E in the serum of the E and E+P-treated animals was 136.5±15 pg/ml and the concentration of P in the serum of the E+P-treated animals was 8.17±1.15 ng/ml. The concentrations of E and P in the serum of the untreated spayed control animals were 11.0 ± 0.1 pg/ml and 0.16±0.13 ng/ml, respectively (significantly different from treated animals by ANOVA, p \<0.01).

Discussion {#S17}
==========

Dendritic spine extrusion and remodeling is a multi-step process that requires actin reorganization. Actin reorganization is a process of enucleation and branching. Filopodia precede spine formation and glutamate promotes filopodia extensions. When filopodia contact an axon, or glutamatergic buton, they may be transformed into spines. This involves decreased motility, shortening of the neck and growth of the head ([@R2]--[@R4]). The dynamic organization of the actin cytoskeleton provides the force for filopodia extrusion and spine morphogenesis. It is regulated by small GTPases of the Rho family, in particular RhoA, Rac1 and CDC42. These G-Proteins function as molecular switches in signal transduction pathways by cycling between an active GTP-bound and an inactive GDP-bound state. RhoA controls stress fiber formation and the attachment of contractile bundles of actin and myosin filaments to the cell membrane at points of focal adhesion, where integrin clusters are present. Rac1 and CDC42 signal transduction pathways lead to actin rearrangements in the form of filopodia (microspikes). Rac1 and RhoA bind to and specifically activate their downstream effectors, which are either kinases such as ROCK (Rho-Associated Coiled-Coil-Containing Protein Kinase), PAK (p21-Activated Kinase) and PI5K (Phosphatidylinositol-5-OH Kinase) or scaffolding proteins such as GDIA, WASP (Wiskott-Aldrich syndrome protein) and IRSp53. Constitutively active GDIA lacking Rho-binding domains cooperates with activated ROCK to form stress fibers. PAK activates LIM-kinases (LIMK1 and LIMK2) to phosphorylate cofilins. This allows signals flowing through Rho family GTPases to coordinate the initiation of new filaments through WASP and the ARP2/3 complex. GTP-bound RhoA activates ROCK (Rho-associated kinase), which phosphorylates the myosin-binding subunit of MLCK (Myosin Light Chain Kinase, also known as MYLK), inactivating it and thereby preventing MLC dephosphorylation. As a result, RhoA activation leads to an accumulation of the phosphorylated MLC and, subsequently, to the stimulation of actomyosin ATPase activity. CDC42 and IRSp53 activation of WAVE (WASP-family Verprolin-Homologous Protein), another member of the WASP family, also induces actin alterations in response to upstream signals. In addition, activation of Rac1 can activate PI5K, which stimulates biosynthesis of PIP2 (Phosphatidylinositol-4, 5-Bisphosphate) and leads to promotion of actin assembly from profilin and gelsolin ([@R14]--[@R16]).

We found that E or E+P increased gene expression on the microarray of RhoA, Rac1 and CDC42 and their downstream effectors Pak1, Rock, PIP5K, IrSp53, WASP and WAVE in serotonin neurons. In addition, E or E+P increased gene expression of the actin and myosin regulatory proteins MLC, cofilin, gelsolin, profilin and ARP2/3. MLCK, also known as MYLK, was confounding. Two probe sets increased and three probe sets decreased. We show two probe sets in [Table 2](#T2){ref-type="table"}, named MLCK and MYLK, but these seem to be the same or similar genes on the microarray. With qRT-PCR primers based upon the decreased probe sets there was a decrease in MLCK expression. Of interest, the decrease in gene expression of CRIPAK and MLCK could act to promote accumulation of phosphorylated MLC and its stimulation of actomyosin ATPase activity. The decrease in gene expression of LIMK2 is puzzling, but it suggests that the Rac/PIP5k/gelsolin:profilin and the CDC42/IRSp53/WASP/WAVE/ARP2/3 pathways may play a more prominent role in dendritic spine proliferation in serotonin neurons. Most of these gene expression changes were confirmed with nested qRT-PCR, which strongly indicates that the microarray reports are accurate. It was noted that some genes responded to E alone, some genes responded similarly to E and E+P and other genes responded to only E+P. These responses indicate that P may have different actions depending on the gene in question. It may reverse the action of E, it may have no effect yielding a similar response in E and E+P treated groups, or it may act solely after E priming. Each of these types of responses has been observed in other systems. However, in order to explain them, a great deal more information is needed such as the steroid receptor response elements in each promoter.

It is noteworthy that 31 other guanidine exchange factor (GEF) probe sets were changed 2-fold or greater with E or E+P treatment including Rap GEFs 2,3,6 and 7; Rho rac GEFs 2,7,9, and 17; GEF-T, Kaliren, spectrin and FYVE (CMT4H, RhoGEF and PH containing domain 4). In addition, 36 probe sets with GTPase activating activity (GAPs) were changed 2-fold or greater with E or E+P treatment including RAB GAP1, RAB GAP150, RAB3 GAP, and Rho GAPs 5, 15, 26.

These changes in gene expression indicate that E and/or E+P promote dendritic spine proliferation on the dendritic arbor of serotonin neurons. This action would play a central role in governing the excitatory input to the serotonin neurons. Dendritic spines express excitatory glutamate receptors, both ionotroic and metabotropic, and the maintenance of a spine requires continuous glutamate signals from afferent neurons ([@R3], [@R4]). Indeed, AMPA receptors can promote spine formation, transformation, stabilization and maintenance. Moreover, inhibition of synaptic transmission in hippocampal slices causes spine loss and atrophy ([@R17], [@R18]).

The ability of E to induce spine proliferation is well documented in the hippocampus ([@R19], [@R20]), hypothalamus ([@R21]), cerebellum ([@R22]) and cortex ([@R23], [@R24]) so the responses of the serotonin neurons to ovarian hormones may be a general phenomena. However, analysis of gene expression upstream of actin reorganization was lacking in any area. Nonetheless, it is now necessary to demonstrate that the changes observed in gene expression translate to protein expression and spine proliferation on serotonin neurons.

The ability of estrogen to increase dendritic spines in the hippocampus involves NMDA receptor activity ([@R19]) and CREB activation ([@R25]). Additional work has shown that estrogen and NMDA receptor activation increase dendritic spine number in the developing hypothalamus, which is dependent on an increase in presynaptic glutamate release. In turn, the estrogen-enhanced glutamate release occurs via a nongenomic mechanism and activation of PI3 kinase ([@R21]).

In light of these reports, it is important to speculate whether changes in genes related to dendritic spine proliferation in serotonin neurons are due to a direct action of E or P via nuclear steroid receptors or, are due to an indirect action via increased glutamate release, or both. We have shown that serotonin neurons express ERβ and PR ([@R7], [@R8], [@R26]), and these receptors are gene transcription factors. Thus, it is reasonable to think that the regulation of gene expression is due to the activity of these transcription factors perhaps causing an increase in filopodia. Nonetheless, an increase in extracellular glutamate may also play a pivotal role and contribute to the transformation of filopodia to mature spines. One would predict glutamate to increase with E or E+P, but as noted above, the gene expression patterns varied. For example, E treatment likely increased glutamate, but some genes increased and others did not. Likewise, glutamate may be increased with supplemental P treatment, however some genes increased, others were equivalent with E treatment, and others were suppressed. It will be hard to test this notion in whole monkeys, or even monkey raphe slices, but with our development of embryonic stem cell-derived serotonin neurons in culture ([@R27]), we may begin to unravel the mechanisms involved.

Summary {#S18}
-------

Altogether, the data indicate that administration of ovarian steroids to ovariectomized monkeys for 1 month alters gene expression in serotonin neurons in a manner that would promote dendritic spine protrusion and an increase in excitatory synapses. This action would enhance serotonin neurotransmission and in turn, improve mood and decrease anxiety.

We are deeply grateful to the dedicated staff of the Division of Animal Resouces including the staff of the Departments of Surgery and Pathology for their expertise and helpfulness in all aspects of monkey management. The staff of the OHSU Gene Microarray Shared Resource was essential for this study.
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![Chart illustrating the key Rho GTPases and their downstream effectors for actin and myosin activation leading to dendritic spine protrusion and transformation. RNA extracted from laser captured serotonin neurons was labeled and hybridized to the Rhesus Affymetrix GeneChip (n=2 animals/treatment) and the results were analyzed with GeneSifter. The genes in red increased 2-fold or greater and the genes in blue decreased 2-fold or greater with E or E+P treatment compared to ovariectomized placebo treated controls.](nihms128016f1){#F1}

![Histograms illustrating changes in gene expression obtained with nested qRT-PCR on RNA extracted from laser captured serotonin neurons (n=3 animals/treatment). The Rho GTPases, RhoA, and Rac1 significantly increased with E alone (ANOVA p\<0.0002 and 0.00115, respectively) whereas CDC42 increased with E and E+P (ANOVA p\<0.05). Downstream effectors ROCK2 increased with E+P (ANOVA p\<0.0047) whereas PIP5K and IRSp53 increased with E alone (ANOVA p\<0.05 and \#t-test p\<0.0114, respectively).\
The variance in IRSp53 in the E+P treated group was significantly different from the ovx group (^**+**^F test p\<0.0028).\
**\*** p\<0.05 different from ovx control with Student-Newman-Keuls posthoc pairwise comparison after ANOVA.](nihms128016f2){#F2}

![Histograms illustrating changes in gene expression obtained with nested qRT-PCR on RNA extracted from laser captured serotonin neurons (n=3 animals/treatment). Intermediaries WAVE and WASP were significantly increased with E treatment, respectively (ANOVA p\< 0.0129 and \#t-test p\<0.0001). The variance in WASP in the E+P treated group was significantly different from the ovx group (^**+**^F test p\<0.0027). The actin regulatory proteins ARP3 and cofilin significantly increased with E and E+P treatment (ANOVA p\<0.0329 and p\<0.0093, respectively). However, gelsolin and profilin increases only with E+P (ANOVA p\<0.0029 and p\<0.0001, respectively).\
**\*** p\<0.05 different from ovx control with Student-Newman-Keuls posthoc pairwise comparison after ANOVA.](nihms128016f3){#F3}

![Histograms illustrating changes in gene expression obtained with nested qRT-PCR on RNA extracted from laser captured serotonin neurons (n=3 animals/treatment). Downstream of Rac1, MLCK was significantly decreased by E and E+P treatment (ANOVA p\<0.0166) whereas LIMK2 was significantly decreased by E+P treatment (\#t-test p\<0.05; F-test p\<0.0001). The endogenous Pak1 inhibitor, CRIPAK, was significantly decreased by E and E+P treatment (ANOVA p\<0.0001).\
**\*** p\<0.05 different from ovx control with Student-Newman-Keuls posthoc pairwise comparison after ANOVA.](nihms128016f4){#F4}

###### 

Sequence of the external and internal primers for nested qRT-PCR on mRNA from laser captured serotonin neurons.

  Synaptic Plasticity Primers                                                                                                            
  ----------------------------- ------ -------------------------- ------- ------ ---------- ------ ----------------------------- ------- -----
  RhoA                                                                           Profilin                                                
                                ExtF   TGGGGCAGGAAGATTATGATCG     65.3    436               ExtF   GGCGCTGCGGTAAGGAG             63.05   305
                                ExtR   GCAGCTCTCGTAGCCATTTCA      62.85                     ExtR   AGCTCTGCCGACAGCAACAT          63.44   
                                IntF   CCCTCTCCTACCCAGATACCG      62.08   251               IntF   CCGCCGCTGGTTAGTCAG            62.9    251
                                IntR   CCCAAAAAGCACCAATCCTGTT     64.37                     IntR   CTCTACCAGCTCTGCCGACAG         62.5    
  Rock2                                                                          CDC42                                                   
                                ExtF   GGTTCGTCATAAGGCATCACA      60.09   548               ExtF   ACGACCGCTGAGTTATCCACA         62.94   351
                                ExtR   CCCCCACTAGCATCTCAAAAAG     62.1                      ExtR   TTCTTCGGTTCTGGAGGCTC          61.81   
                                IntF   ATGCCTGGTGGAGACCTTGTA      61.5    298               IntF   TTTTCAGTGGTCTCTCCATCTTCAT     62.4    202
                                IntR   AGTAACCATCACCCCCTTGTG      61.04                     IntR   GGTCACGGGCCAGCTTTT            63.5    
  MLCK                                                                           IRSp53                                                  
                                ExtF   GCCACGTGAACCTGATCCA        63.16   551               ExtF   GGCTTTATCACCAGGATGTCACA       63.3    463
                                ExtR   CAGCAACCGGGAAACAAAGT       62.34                     ExtR   CGGCTTTACCTTGAACTGAGGT        61.85   
                                IntF   GACCTCAAGCCGGAGAACATATT    62.81   251               IntF   TTTGGAAACATCTGTGGACTCTGTT     63.2    263
                                IntR   TCTGCATCTGTTTCCCCTAGAAAT   62.4                      IntR   GGTGCACTCTCCTAGCATGCT         61.9    
  CRIPAK                                                                         WAVE                                                    
                                ExtF   CTCGCTTTGTGCCAATGTG        61.43   1361              ExtF   TTCAACTCCTCCCCCTCCA           62.94   456
                                ExtR   CCTCTCCTCTTCCATCTCATCC     61.2                      ExtR   TTAGCTTCCTGTTCACGCTGC         62.8    
                                IntF   TCACACAAAGCCCTGGCAT        62.6    154               IntF   ACCTGGCATTCGACCATCAT          62.6    253
                                IntR   CCTACGTTATCTCGAGGTGCAG     61.1                      IntR   ACGCTGCTCTTCTACTTTGCG         62.09   
  LIMK2                                                                          WASP                                                    
                                ExtF   AGGTGGAGGATGCAATTAGCC      62.5    356               ExtF   GACAGAGCAGGCTGGGAGAA          63.02   463
                                ExtR   CAGGACCTCCCCATGGATTA       62.01                     ExtR   TGCTATCAGGCTTTGAGCCC          62.6    
                                IntF   GTTGATTGAACATGACCCCGT      61.9    251               IntF   GGTCTGGGAGGACTGTTCCA          62.47   208
                                IntR   CAACGAAGGGATTCTGAGCG       63.1                      IntR   GGTTCCTCTGAGGCTCTGGG          63.56   
  Cofilin1                                                                       ARP3                                                    
                                ExtF   GAAAAGCGCGCGAGATC          63.5    451               ExtF   TGCTAAGGCAGTAAAGGAGCG         61.87   453
                                ExtR   TGATGGCATCCTTGGAACTG       62.02                     ExtR   CGCTGCATGTGGTGTGTAATG         63.48   
                                IntF   GGTGTGGCTGTCTCTGATGGT      62.5    259               IntF   ATGATACAGATGGGTCAAAATGGATTA   62.7    252
                                IntR   GCATCATAGAGGGCGTAGCG       63.07                     IntR   TGAACATGGTTGAACCTCCAGA        62.7    
  RAC1                                                                           GAPDH                                                   
                                ExtF   TTGTGGTAGATGGAAAACCGG      61.9    351               ExtF   CCCTCCAAAATCGAGTGTGGT         60      315
                                ExtR   TGTGAGCACCAAACACTCCAG      62.3                      ExtR   AGGAAAACTGGCAGTGATGGC         60      
                                IntF   TGTCCGTGCAAAGTGGTATCC      63.1    182               IntF   CTGACACTGAGTACGTCGTGGA        57      268
                                IntR   TTTTGCAGCACCAATCTCCTT      62.03                     IntR   TGGACTGTGGTCATGAGTCCTT        58      
  PIP5                                                                           PPIA                                                    
                                ExtF   TTCAAGCTTTTGAAAGGCCTCAC    62.93   405               ExtF   TCGACGGCGAGCCCCT              59      451
                                ExtR   GCATTGTCATCCTGCACTTCC      62.9                      ExtR   GTCCACAGTCAGCAATGGTGAT        59      
                                IntF   TTCCATCGCCGCCTTAAAAG       63.3    201               IntF   TCGTGCTCTGAGCACTGGAG          59      301
                                IntR   GAAATTGTGGTCGCCAAGGA       63.25                     IntR   CATGCCTTCTTTCACTTTGCC         58      
  Gelsolin                                                                       GUSP                                                    
                                ExtF   GCCACCCTTCCTCTCCATCT       62.8    454               ExtF   TGATCGCTCACACCAAAGCTT         59      453
                                ExtR   CTGGAAAGGTAGGACAAGCCC      62.2                      ExtR   TTTTGGTTGTCTCTGCCGAGT         58      
                                IntF   TGTGGCTGATGAGAACCCCT       63      251               IntF   ACTTCGGGCACCTGGAGTT           58      
                                IntR   CCCGCCAGTTCTTGAAGAACT      62.9                      IntR   TCATGAAATCGGCAAATTCC          58      253

###### 

Average Signal Intensity of 2 microarray chips per group for selected plasticity probe sets.

                                                  OVX    E      E+P
  ----------------------------------------------- ------ ------ ------
  Probe Sets                                                    
  Rho A                                           1057   2436   1682
  Rac (probe set 1)                               130    1570   687
  Rac (probe set 2)                               2099   6242   3468
  cdc42 (probe set 1)                             1876   3790   2682
  cdc42 (probe set 2)                             461    1136   921
  Rock                                            475    1110   723
  CRIPAK                                          365    188    150
  Pak 1                                           527    2049   780
  PIP5K1B                                         143    390    221
  IRSp53                                          292    831    339
  WAVE (WASPIP[\*](#TFN1){ref-type="table-fn"})   568    1275   881
  N-WASP (WASL)                                   836    3006   1619
  LIMK2                                           86     8      44
  MLCK                                            693    43     447
  MYLK                                            549    1923   730
  MLC                                             205    778    534
  Cofilin                                         487    2255   1321
  Gelsolin                                        1245   3182   1910
  Profilin                                        2066   4932   3484
  ARP2/3 subunit2                                 154    799    277
  ARP2/3 subunit3                                 380    1366   809
  ARP2/3 subunit5                                 20     554    268

NWASP/WASL interacting protein
